Your browser doesn't support javascript.
loading
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.
Casan, Joshua Ml; Barraclough, Alison; Shortt, Jake; Hawkes, Eliza A.
Afiliação
  • Casan JM; Haematology Department, Monash Health, Melbourne, VIC, Australia; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Barraclough A; The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
  • Shortt J; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Hawkes EA; The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia. Electronic address: Eliza.Hawkes@onjcri.org.au.
Lancet Haematol ; 6(3): e119, 2019 03.
Article em En | MEDLINE | ID: mdl-30824036
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Padrão de Cuidado Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Padrão de Cuidado Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article